Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK-104-CR vs Livalo IR in Hyperlipidemia
NCT02799758Phase 3Withdrawn
- Start
- Feb 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin in primary hyperlipidemia, mixed dyslipidemia. Planned start Feb 2016; status: withdrawn.
02
Drugs
pitavastatin
03
Conditions
primary hyperlipidemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT02799758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799758.